Cardiac manifestations of Fabry disease in G3Stg/GlaKO and GlaKO mouse models-Translation to Fabry disease patients.
Fabry disease (FD) is an X-linked disorder of glycosphingolipid metabolism caused by mutations in the GLA gene encoding alpha-galactosidase A (α-Gal). Loss of α-Gal activity leads to progressive lysosomal accumulation of α-Gal substrate, predominately globotriaosylceramide (Gb3) and its deacylated d...
Saved in:
Main Authors: | Abirami Kugadas, Pietro Artoni, Wanida Ruangsiriluk, Meng Zhao, Natalia Boukharov, Rizwana Islam, Dmitri Volfson, Katayoun Derakhchan |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0304415 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fabry Disease and Early Stroke
by: U. Feldt-Rasmussen
Published: (2011-01-01) -
Matrix Gla Protein Binds to Fibronectin and Enhances Cell Attachment and Spreading on Fibronectin
by: Satoru Ken Nishimoto, et al.
Published: (2014-01-01) -
Matrix Gla Protein and Nitric Oxide Synthase-3 Genetic Variants in Chronic Kidney Disease and Their Relation with Cardiovascular Risk
by: G. Priyadarshini, et al.
Published: (2024-01-01) -
Prevalence of Fabry Disease among Patients with Parkinson’s Disease
by: Alexandra Lackova, et al.
Published: (2022-01-01) -
Major Organic Involvement in Women with Fabry Disease in Argentina
by: Fernando Perretta, et al.
Published: (2018-01-01)